Puma Biotechnology Inc
PBYI
$10.12-1.65%
End of day · as of Oct 13, 2026, 8:30 PM ET
Mkt cap
$165.29M
EV/Sales
0.69
P/E ratio
N/A
FY2025 Revenue
$228.37M
EPS (TTM)
$0.51
Gross Margin (FY2025)
74.53%
Profit Margin (FY2025)
13.62%
Beta
1.28
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported PBYI revenue for 2025-12-31 was $228.4M. Net income was $31.1M. Revenue was down 0.9% from 2024-12-31 to 2025-12-31. PBYI currently screens at market cap $165.3M.
Use this PBYI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PBYI income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Puma Biotechnology Inc (PBYI) is a biotechnology company in the Healthcare sector.
Latest cached Puma Biotechnology Inc (PBYI) revenue for Dec 31, 2025 was $228.4M. Net income was $31.1M. Statements: https://lician.com/financials/pbyi
Puma Biotechnology Inc (PBYI) market capitalization is $165.3M on the latest cached snapshot.
Puma Biotechnology Inc (PBYI) cached previous close $10.29; day range $10.12 – $10.27; volume 289,314. Session quote: https://lician.com/quote/pbyi
Puma Biotechnology Inc (PBYI) latest cached earnings event is "PBYI earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings